Peter Riederer

48.4k total citations · 9 hit papers
534 papers, 35.4k citations indexed

About

Peter Riederer is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Peter Riederer has authored 534 papers receiving a total of 35.4k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Cellular and Molecular Neuroscience, 203 papers in Neurology and 150 papers in Molecular Biology. Recurrent topics in Peter Riederer's work include Parkinson's Disease Mechanisms and Treatments (176 papers), Neuroscience and Neuropharmacology Research (100 papers) and Alzheimer's disease research and treatments (86 papers). Peter Riederer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (176 papers), Neuroscience and Neuropharmacology Research (100 papers) and Alzheimer's disease research and treatments (86 papers). Peter Riederer collaborates with scholars based in Germany, Austria and United States. Peter Riederer's co-authors include Moussa B. H. Youdim, M. Gerlach, K. A. Jellinger, Klaus‐Peter Lesch, Dorit Ben‐Shachar, Manfred Gerlach, Luigi Zecca, Johannes Kornhuber, Gavin P. Reynolds and E. Sofić and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Peter Riederer

532 papers receiving 34.5k citations

Hit Papers

Allelic Variation of Human Serotonin Transporter Gene Exp... 1988 2026 2000 2013 1996 2004 1989 1994 1995 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Allelic Variation of Human Serotonin Transporter Gene Expression
    1996 1.8k citations Peter Riederer et al. Journal of Neurochemistry profile →
  2. Iron, brain ageing and neurodegenerative disorders
    2004 1.5k citations Moussa B. H. Youdim, Peter Riederer et al. profile →
  3. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains
    1989 1.1k citations Peter Riederer, E. Sofić et al. Journal of Neurochemistry profile →
  4. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
    1994 800 citations Peter Riederer et al. profile →
  5. Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
    1995 628 citations Thomas Müller, Manfred Gerlach et al. profile →
  6. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
    1998 609 citations K. A. Jellinger, Peter Riederer et al. Journal of Neural Transmission profile →
  7. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
    1988 591 citations E. Sofić, Peter Riederer et al. Journal of Neural Transmission profile →
  8. Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
    1994 591 citations Peter Riederer, Moussa B. H. Youdim et al. Journal of Neurochemistry profile →
  9. Organization of the human serotonin transporter gene
    1994 504 citations Peter Riederer et al. Journal of Neural Transmission profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Riederer Germany 91 12.2k 11.0k 9.8k 7.6k 6.0k 534 35.4k
Moussa B. H. Youdim Israel 102 10.2k 0.8× 12.4k 1.1× 10.0k 1.0× 7.6k 1.0× 5.0k 0.8× 553 37.1k
Isidró Ferrer Spain 101 11.4k 0.9× 8.3k 0.8× 20.4k 2.1× 12.8k 1.7× 7.7k 1.3× 910 42.1k
Edith G. McGeer Canada 92 14.3k 1.2× 7.7k 0.7× 10.3k 1.0× 10.3k 1.4× 10.0k 1.7× 393 34.8k
Patrick L. McGeer Canada 106 13.8k 1.1× 8.6k 0.8× 12.6k 1.3× 15.2k 2.0× 14.6k 2.4× 492 42.7k
Jau‐Shyong Hong United States 92 14.6k 1.2× 7.0k 0.6× 12.6k 1.3× 6.9k 0.9× 15.2k 2.5× 534 38.0k
Peter Jenner United Kingdom 81 12.5k 1.0× 15.2k 1.4× 9.3k 0.9× 4.2k 0.6× 3.3k 0.5× 463 31.0k
Costantino Iadecola United States 111 7.5k 0.6× 8.6k 0.8× 12.0k 1.2× 12.4k 1.6× 18.5k 3.1× 420 52.3k
M. Flint Beal United States 105 15.1k 1.2× 11.7k 1.1× 19.9k 2.0× 7.8k 1.0× 4.2k 0.7× 273 36.4k
Donald L. Price United States 108 16.3k 1.3× 9.8k 0.9× 16.9k 1.7× 17.3k 2.3× 6.2k 1.0× 365 44.1k
M. Flint Beal United States 98 9.0k 0.7× 9.5k 0.9× 19.5k 2.0× 10.2k 1.3× 4.2k 0.7× 221 36.5k

Countries citing papers authored by Peter Riederer

Since Specialization
Citations

This map shows the geographic impact of Peter Riederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Riederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Riederer more than expected).

Fields of papers citing papers by Peter Riederer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Riederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Riederer. The network helps show where Peter Riederer may publish in the future.

Co-authorship network of co-authors of Peter Riederer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Riederer. A scholar is included among the top collaborators of Peter Riederer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Riederer. Peter Riederer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sian‐Hülsmann, Jeswinder & Peter Riederer. (2024). Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view. Journal of Neural Transmission. 131(12). 1429–1453. 9 indexed citations
2.
Ministrini, Stefano, Yustina M. Puspitasari, Simon Kraler, et al.. (2023). Long non-coding RNAs H19 and NKILA are associated with the risk of death and lacunar stroke in the elderly population. European Journal of Internal Medicine. 123. 94–101. 4 indexed citations
3.
Riederer, Peter, Daniela Berg, Nicolas Casadei, et al.. (2019). α-Synuclein in Parkinson’s disease: causal or bystander?. Journal of Neural Transmission. 126(7). 815–840. 83 indexed citations
4.
Andreazza, Ana C., Brisa S. Fernandes, Catherine Toben, et al.. (2019). Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity – a consensus of the Biomarkers Task Force from the WFSBP. The World Journal of Biological Psychiatry. 20(5). 340–351. 18 indexed citations
5.
Müller, Thomas, Peter Riederer, & Edna Grünblatt. (2017). Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson Disease. Clinical Neuropharmacology. 40(5). 208–211. 22 indexed citations
6.
Durrenberger, Pascal F., Edna Grünblatt, Camelia Maria Monoranu, et al.. (2012). Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study. Parkinson s Disease. 2012. 1–16. 55 indexed citations
7.
Sian‐Hülsmann, Jeswinder, Silvia Mandel, Moussa B. H. Youdim, & Peter Riederer. (2010). The relevance of iron in the pathogenesis of Parkinson’s disease. Journal of Neurochemistry. 118(6). 939–957. 284 indexed citations
8.
Mößner, Rainald, Olya Mikova, Eleni Koutsilieri, et al.. (2007). Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression. The World Journal of Biological Psychiatry. 8(3). 141–174. 195 indexed citations
9.
Riederer, Peter, L. Lachenmayer, & Gerd Laux. (2004). Clinical Applications of MAO-Inhibitors. Current Medicinal Chemistry. 11(15). 2033–2043. 184 indexed citations
10.
Yamada, Shingo, Megumi Yamamoto, Hiroki Ozawa, Peter Riederer, & Toshikazu Saito. (2003). Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. Journal of Neural Transmission. 110(6). 671–680. 108 indexed citations
11.
Riederer, Peter. (2003). Monoamine Oxidase-B Inhibition in Alzheimer's Disease. NeuroToxicology. 25(1-2). 271–277. 218 indexed citations
12.
Reif, Andreas, et al.. (2003). NADPH-diaphorase staining reveals new types of interneurons in human putamen. Brain Research. 980(1). 92–99. 17 indexed citations
13.
Ozawa, Hiroki, Wataru Ukai, Johannes Kornhuber, et al.. (1999). Postnatal ontogeny of GTP binding protein in the human frontal cortex. Life Sciences. 65(22). 2315–2323. 3 indexed citations
14.
Nishi, Nobuyuki, Hiroki Ozawa, Toshikazu Saito, et al.. (1998). Measurement of receptor-mediated functional activation of G proteins in postmortem human brain membranes. Brain Research. 789(1). 84–91. 11 indexed citations
15.
Bringmann, Gerhard, Ralf God, Doris Feineis, et al.. (1995). The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.. PubMed. 46. 235–44. 28 indexed citations
16.
Kornhuber, Johannes, Wolfgang Retz, & Peter Riederer. (1995). Slow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs?. PubMed. 46. 315–23. 48 indexed citations
17.
Lange, Klaus W., Johannes Kornhuber, & Peter Riederer. (1994). GLUTAMATERGIC MECHANISMS IN THE BRAIN IN MOVEMENT-DISORDERS AND SCHIZOPHRENIA. University of Regensburg Publication Server (University of Regensburg). 1 indexed citations
18.
19.
Fritze, Jürgen, et al.. (1990). Cholinergic-adrenergic balance: Part 2. Relationship between drug sensitivity and personality. Psychiatry Research. 34(3). 271–279. 11 indexed citations
20.
Riederer, Peter, et al.. (1978). CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 121–31. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moussa B. H. Youdim Breakdown of academic impact, for papers by Isidró Ferrer Breakdown of academic impact, for papers by Edith G. McGeer Breakdown of academic impact, for papers by Patrick L. McGeer Breakdown of academic impact, for papers by Jau‐Shyong Hong Breakdown of academic impact, for papers by Peter Jenner Breakdown of academic impact, for papers by Costantino Iadecola Breakdown of academic impact, for papers by M. Flint Beal Breakdown of academic impact, for papers by Donald L. Price Breakdown of academic impact, for papers by M. Flint Beal
Rankless by CCL
2026